Results 201 to 210 of about 315,758 (337)
Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes. [PDF]
Edward S. Horton+5 more
openalex +1 more source
ABSTRACT The popularity of incretin‐based therapies has increased substantially over the past several years due to their clinically significant efficacy for weight loss and positive impact on weight‐related comorbid conditions, yet, few clinical practice guidelines for the management of overweight and obesity have been updated to incorporate these ...
Sara Lingow+6 more
wiley +1 more source
Predictors of glycemic control in insulin-using adults with type 2 diabetes. [PDF]
Gregory A. Nichols+3 more
openalex +1 more source
Justin Easow Sam, Mala Dharmalingam
openaire +4 more sources
This study demonstrates variation in photo‐induced secretion of insulin and amylin from Channelrhodopsin‐2 expressing MIN6 cells under different irradiation conditions. For the first time, an alteration in the relative ratio of amylin: insulin is observed with varying irradiation conditions.
Nidhi Maharwal+3 more
wiley +1 more source
The impact of learning disabilities on control, management, and outcomes of type 2 diabetes mellitus in the UK: an observational cohort study using the Clinical Practice Research Datalink. [PDF]
Wing A, Mathur R.
europepmc +1 more source
Acute Fructose Administration Decreases the Glycemic Response to an Oral Glucose Tolerance Test in Normal Adults1 [PDF]
Mary Courtney Moore+3 more
openalex +1 more source
Abstract Impaired awareness of hypoglycemia (IAH) impacts 25%–30% of individuals with type 1 diabetes mellitus (T1D), potentially leading to severe outcomes due to reduced symptom perception. Naloxone, a mu‐opioid receptor antagonist, shows promise as a preventive measure against IAH.
Omar N. Al Yacoub+9 more
wiley +1 more source